BACKGROUND: Quantum dots (QDs) have numerous possible applications for in vivo imaging. However, toxicity data are scarce. OBJECTIVES: To determine the acute in vivo toxicity of QDs with carboxyl surface coating (carboxyl-QDs) and QDs with amine surface coating (amine-QDs), we investigated the inflammatory properties, tissue distribution, and prothrombotic effects after intravenous injection. METHODS: We performed particle characterization by transmission electron microscopy and dynamic light scattering. Carboxyl-QDs and amine-QDs were intravenously injected in mice (1.44-3,600 pmol/mouse). At different time intervals, analyses included fluorescence microscopy, blood cell analysis, bronchoalveolar lavage, wet and dry organ weights, and cadmium concentration in various organs. We examined the prothrombotic effects in vivo by assessing the effect of pretreatment with the anticoagulant heparin and by measuring platelet activation (P-selectin), and in vitro by platelet aggregation in murine and human platelet-rich plasma exposed to QDs (1.44-1,620 pmol/mL). RESULTS: At doses of 3,600 and 720 pmol/mouse, QDs caused marked vascular thrombosis in the pulmonary circulation, especially with carboxyl-QDs. We saw an effect of surface charge for all the parameters tested. QDs were mainly found in lung, liver, and blood. Thrombotic complications were abolished, and P-selectin was not affected by pretreatment of the animals with heparin. In vitro, carboxyl-QDs and amine-QDs enhanced adenosine-5'-diphosphate-induced platelet aggregation. CONCLUSION: At high doses, QDs caused pulmonary vascular thrombosis, most likely by activating the coagulation cascade via contact activation. Our study highlights the need for careful safety evaluation of QDs before their use in human applications. Furthermore, it is clear that surface charge is an important parameter in nanotoxicity.
BACKGROUND: Quantum dots (QDs) have numerous possible applications for in vivo imaging. However, toxicity data are scarce. OBJECTIVES: To determine the acute in vivo toxicity of QDs with carboxyl surface coating (carboxyl-QDs) and QDs with amine surface coating (amine-QDs), we investigated the inflammatory properties, tissue distribution, and prothrombotic effects after intravenous injection. METHODS: We performed particle characterization by transmission electron microscopy and dynamic light scattering. Carboxyl-QDs and amine-QDs were intravenously injected in mice (1.44-3,600 pmol/mouse). At different time intervals, analyses included fluorescence microscopy, blood cell analysis, bronchoalveolar lavage, wet and dry organ weights, and cadmium concentration in various organs. We examined the prothrombotic effects in vivo by assessing the effect of pretreatment with the anticoagulant heparin and by measuring platelet activation (P-selectin), and in vitro by platelet aggregation in murine and human platelet-rich plasma exposed to QDs (1.44-1,620 pmol/mL). RESULTS: At doses of 3,600 and 720 pmol/mouse, QDs caused marked vascular thrombosis in the pulmonary circulation, especially with carboxyl-QDs. We saw an effect of surface charge for all the parameters tested. QDs were mainly found in lung, liver, and blood. Thrombotic complications were abolished, and P-selectin was not affected by pretreatment of the animals with heparin. In vitro, carboxyl-QDs and amine-QDs enhanced adenosine-5'-diphosphate-induced platelet aggregation. CONCLUSION: At high doses, QDs caused pulmonary vascular thrombosis, most likely by activating the coagulation cascade via contact activation. Our study highlights the need for careful safety evaluation of QDs before their use in human applications. Furthermore, it is clear that surface charge is an important parameter in nanotoxicity.
Authors: Sungjee Kim; Yong Taik Lim; Edward G Soltesz; Alec M De Grand; Jaihyoung Lee; Akira Nakayama; J Anthony Parker; Tomislav Mihaljevic; Rita G Laurence; Delphine M Dor; Lawrence H Cohn; Moungi G Bawendi; John V Frangioni Journal: Nat Biotechnol Date: 2003-12-07 Impact factor: 54.908
Authors: X Michalet; F F Pinaud; L A Bentolila; J M Tsay; S Doose; J J Li; G Sundaresan; A M Wu; S S Gambhir; S Weiss Journal: Science Date: 2005-01-28 Impact factor: 47.728
Authors: Neera V Gopee; Dean W Roberts; Peggy Webb; Christy R Cozart; Paul H Siitonen; Alan R Warbritton; William W Yu; Vicki L Colvin; Nigel J Walker; Paul C Howard Journal: Toxicol Sci Date: 2007-04-02 Impact factor: 4.849
Authors: Jasmina Lovrić; Hassan S Bazzi; Yan Cuie; Genevieve R A Fortin; Françoise M Winnik; Dusica Maysinger Journal: J Mol Med (Berl) Date: 2005-02-02 Impact factor: 4.599
Authors: Hiroshi Kataoka; Justin R Hamilton; David D McKemy; Eric Camerer; Yao-Wu Zheng; Abby Cheng; Courtney Griffin; Shaun R Coughlin Journal: Blood Date: 2003-07-17 Impact factor: 22.113
Authors: Daniel R Larson; Warren R Zipfel; Rebecca M Williams; Stephen W Clark; Marcel P Bruchez; Frank W Wise; Watt W Webb Journal: Science Date: 2003-05-30 Impact factor: 47.728
Authors: Ying-Ying Huang; Sulbha K Sharma; Tianhong Dai; Hoon Chung; Anastasia Yaroslavsky; Maria Garcia-Diaz; Julie Chang; Long Y Chiang; Michael R Hamblin Journal: Nanotechnol Rev Date: 2012-03 Impact factor: 7.848
Authors: Nazanin R Yacobi; Farnoosh Fazllolahi; Yong Ho Kim; Arnold Sipos; Zea Borok; Kwang-Jin Kim; Edward D Crandall Journal: Air Qual Atmos Health Date: 2011-03-01 Impact factor: 3.763
Authors: Lisa A McConnachie; Collin C White; Dianne Botta; Megan E Zadworny; David P Cox; Richard P Beyer; Xiaoge Hu; David L Eaton; Xiaohu Gao; Terrance J Kavanagh Journal: Nanotoxicology Date: 2012-01-20 Impact factor: 5.913
Authors: David K Scoville; Collin C White; Dianne Botta; Lisa A McConnachie; Megan E Zadworny; Stefanie C Schmuck; Xiaoge Hu; Xiaohu Gao; Jianbo Yu; Russell L Dills; Lianne Sheppard; Martha A Delaney; William C Griffith; Richard P Beyer; Richard C Zangar; Joel G Pounds; Elaine M Faustman; Terrance J Kavanagh Journal: Toxicol Appl Pharmacol Date: 2015-10-21 Impact factor: 4.219